Individual risk profiles for postoperative delirium after joint replacement surgery

Area of Science:

• Geriatric Medicine
• Anesthesiology
• Surgical Outcomes

Background:

• Postoperative delirium is common in older adults undergoing joint replacement surgery, affecting nearly half of patients.
• Established risk profiles for developing delirium in this population are lacking.

Purpose of the Study:

• To identify specific risk profiles for postoperative delirium in patients undergoing hip or knee replacement surgery.
• To inform targeted prevention strategies for delirium in this vulnerable patient group.

Main Methods:

• A secondary analysis of a randomized, double-blind, placebo-controlled trial involving 400 patients aged 67-81 undergoing joint replacement.
• Signal detection analysis was used to develop risk profiles based on baseline characteristics, iatrogenic factors, and physiological responses.

Main Results:

• Olanzapine reduced delirium incidence by 63% compared to placebo.
• High-risk profiles included older age (≥74 years) and higher ASA class (≥3) in placebo recipients, or specific combinations of intra-operative morphine, age, and pre-surgical mean arterial pressure (MAP) in olanzapine recipients.
• Low-risk patients receiving olanzapine had higher hematocrit (≥28%) and pre-surgical MAP (≥90 mm Hg).

Conclusions:

• While prophylactic olanzapine decreases delirium, certain patient subsets remain at high risk.
• Reducing delirium risk involves prophylactic olanzapine, optimizing intra-operative perfusion and oxygenation, and limiting opioid administration.